Gastroenterology
Volume 128, Issue 4 , Pages 882-890 , April 2005

Colchicine treatment of alcoholic cirrhosis: A randomized, placebo-controlled clinical trial of patient survival

  • Timothy R. Morgan

      Affiliations

    • VA Long Beach Healthcare System, Long Beach, California
    • Corresponding Author InformationAddress requests for reprints to: Timothy R. Morgan, MD, VA Medical Center-11, 5901 E. Seventh Street, Long Beach, California 90822; fax: (562) 826-8023.
    • ,
  • David G. Weiss

      Affiliations

    • VA Medical Center, Perry Point, Maryland
    • ,
  • Bernard Nemchausky

      Affiliations

    • VA Medical Center, Hines, Illinois
    • ,
  • Eugene R. Schiff

      Affiliations

    • VA Medical Center, Miami, Florida
    • ,
  • Bhupinder Anand

      Affiliations

    • VA Medical Center, Houston, Texas
    • ,
  • Francis Simon

      Affiliations

    • VA Medical Center, Denver, Colorado
    • ,
  • Jayashri Kidao

      Affiliations

    • VA Long Beach Healthcare System, Long Beach, California
    • ,
  • Bennet Cecil

      Affiliations

    • VA Medical Center, Louisville, Kentucky
    • ,
  • Charles L. Mendenhall

      Affiliations

    • VA Medical Center, Cincinnati, Ohio
    • ,
  • Douglas Nelson

      Affiliations

    • VA Medical Center, Minneapolis, Minnesota
    • ,
  • Charles Lieber

      Affiliations

    • VA Medical Center, Bronx, New York
    • ,
  • Marcos Pedrosa

      Affiliations

    • VA Medical Center, Boston, Massachusetts
    • ,
  • Lennox Jeffers

      Affiliations

    • VA Medical Center, Miami, Florida
    • ,
  • John Bloor

      Affiliations

    • VA Medical Center, Denver, Colorado
    • ,
  • Lawrence Lumeng

      Affiliations

    • VA Medical Center, Indianapolis, Indiana
    • ,
  • Luis Marsano

      Affiliations

    • VA Medical Center, Lexington, Kentucky
    • ,
  • Craig McClain

      Affiliations

    • VA Medical Center, Lexington, Kentucky
    • ,
  • Girish Mishra

      Affiliations

    • VA Medical Center, Gainesville, Florida
    • ,
  • Brent Myers

      Affiliations

    • VA Medical Center, Gainesville, Florida
    • ,
  • Maria Leo

      Affiliations

    • VA Medical Center, Bronx, New York
    • ,
  • Yelena Ponomarenko

      Affiliations

    • VA Medical Center, Bronx, New York
    • ,
  • Derek Taylor

      Affiliations

    • VA Long Beach Healthcare System, Long Beach, California
    • ,
  • Antonio Chedid

      Affiliations

    • VA Medical Center, North Chicago, Illinois
    • ,
  • Samuel French

      Affiliations

    • Harbor-UCLA Medical Center, Torrance, California
    • ,
  • Gary Kanel

      Affiliations

    • LAC-USC Medical Center, Los Angeles, California
    • ,
  • Natalie Murray

      Affiliations

    • Baylor Hospital, Dallas, Texas
    • ,
  • Paul Pinto

      Affiliations

    • Private Practice, Denver, Colorado
    • ,
  • Tse-Ling Fong

      Affiliations

    • LAC-USC Medical Center, Los Angeles, California
    • ,
  • Mike R. Sather

      Affiliations

    • VA Medical Center, Albuquerque, New Mexico

Received 13 August 2004 ,Accepted 7 January 2005.

References 

  1. Bell B , Navarro V , Manos M , et al.   The epidemiology of newly-diagnosed chronic liver disease in the United States (findings of a population-based sentinel surveillance) . (abstr) Hepatology . 2001;34:468A
  2. Kershenobich D , Vargas F , Garcia-Tsao G , Perez Tamayo R , Gent M , Rojkind M . Colchicine in the treatment of cirrhosis of the liver . N Engl J Med . 1988;318:1709–1713
  3. Kaplan MM , Alling DW , Zimmerman HJ , et al.   A prospective trial of colchicine for primary biliary cirrhosis . N Engl J Med . 1986;315:1448–1454
  4. Kaplan MM , Schmid C , Provenzale D , Sharma A , Dickstein G , McKusick A . A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis . Gastroenterology . 1999;117:1173–1180
  5. Warnes TW , Smith A , Lee FI , Haboubi NY , Johnson PJ , Hunt L . A controlled trial of colchicine in primary biliary cirrhosis (Trial design and preliminary report) . J Hepatol . 1987;5:1–7
  6. Poupon RE , Huet PM , Poupon R , Bonnand AM , Nhieu JT , Zafrani ES . A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis (UDCA-PBC Study Group) . Hepatology . 1996;24:1098–1103
  7. Ikeda T , Tozuka S , Noguchi O , et al.   Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis (a prospective randomized study) . J Hepatol . 1996;24:88–94
  8. Lin DY , Sheen IS , Chu CM , Liaw YF . A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients . Aliment Pharmacol Ther . 1996;10:961–966
  9. Pitts FN . Colchicine therapy for palmar fibromatosis . N Engl J Med . 1995;333:393
  10. Paolini O , Hebuterne X , Flory P , Charles F , Rampal P . Treatment of pyoderma gangrenosum with colchicine . Lancet . 1995;345:1057–1058
  11. Katz J , Langevitz P , Shemer J , Barak S , Livneh A . Prevention of recurrent aphthous stomatitis with colchicine (an open trial) . J Am Acad Dermatol . 1994;31:459–461
  12. Banodkar DD , al-Suwaid AR . Colchicine as a novel therapeutic agent in chronic bullous dermatosis of childhood . Int J Dermatol . 1997;36:213–216
  13. Cunningham BB , Kirchmann TT , Woodley D . Colchicine for epidermolysis bullosa acquisita . J Am Acad Dermatol . 1996;34:781–784
  14. Wong SS , Tan KC , Goh CL . Long-term colchicine for recalcitrant palmoplantar pustulosis (treatment outcome in 3 patients) . Cutis . 2001;68:216–218
  15. Yurdakul S , Mat C , Tuzun Y , et al.   A double-blind trial of colchicine in Behcet’s syndrome . Arthritis Rheum . 2001;44:2686–2692
  16. Mourelle M , Villalon C , Amezcua JL . Protective effect of colchicine on acute liver damage induced by carbon tetrachloride . J Hepatol . 1988;6:337–342
  17. Mourelle M , Meza MA . Colchicine prevents D-galactosamine-induced hepatitis . J Hepatol . 1989;8:165–172
  18. Muriel P , Quintanar M , Perez-Alvarez V . Effect of colchicine on acetaminophen-induced liver damage . Liver . 1993;13:217–221
  19. Ding AH , Porteu F , Sanchez E , Nathan CF . Down-regulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents . J Exp Med . 1990;71:715–727
  20. Tiegs G , Freudenberg M , Galanos C , Wendel A . Colchicine prevents tumor necrosis factor-induced toxicity in vivo . Infect Immun . 1992;60:1941–1945
  21. Diegelmann RF , Peterkofsky B . Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs . Proc Natl Acad Sci U S A . 1972;69:892–896
  22. Bauer EA , Valle KJ . Colchicine-induced modulation of collagenase in human skin fibroblast cultures (I. Stimulation of enzyme synthesis in normal cells) . J Invest Dermatol . 1982;79:398–402
  23. Aguirre-Cruz L , Calvillo M , Sotelo J . Colchicine, like methylprednisolone, decreases the perilesional fibrosis secondary to a chronic brain granuloma in cats . Exp Mol Path . 1998;95:9–14
  24. Ehrlich HP , Ross R , Bornstein P . Effects of antimicrotubular agents on the secretion of collagen (A biochemical and morphological study) . J Cell Biol . 1974;62:390–405
  25. Poo JL , Feldmann G , Moreau A , Gaudin C , Lebrec D . Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation . J Hepatol . 1993;19:90–94
  26. Guidelines on the Planning and Conduct of Cooperative Studies. Cooperative Studies Program of the VA Office of Research and Development, 2001.
  27. Pugh R , Murray-Lyon I , Dawson J , Pietroni M , Williams R . Transection of the oesophagus for bleeding oesophageal varices . Br J Surg . 1973;60:646–649
  28. Batts K , Ludwig J . Chronic hepatitis (an update on terminology and reporting) . Am J Surg Pathol . 1995;19:1409–1417
  29. Kuncl R , Duncan G , Watson D , Alderson K , Rogawski M , Peper M . Colchicine myopathy and neuropathy . N Engl J Med . 1987;316:1562–1568
  30. Chattopadhyay I , Shetty HG , Routledge PA , Jeffery J . Colchicine induced rhabdomyolysis . Postgrad Med J . 2001;77:191–192
  31. Dufour J , DeLellis R , Kaplan M . Reversibility of hepatic fibrosis in autoimmune hepatitis . Ann Intern Med . 1997;127:981–985
  32. Powell L , Kerr J . Reversal of “cirrhosis” in idiopathic haemochromatosis following long-term intensive venesection therapy . Australas Ann Med . 1970;19:54–57
  33. Poynard T , McHutchison J , Manns M , et al.   Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C . Gastroenterology . 2002;122:1303–1313
  34. Soyer M , Ceballos R , Aldrete J . Reversibility of severe hepatic damage caused by jejunoileal bypass after re-establishment of normal intestinal continuity . Surgery . 1976;79:601–604
  35. Rambaldi A, Gluud C. Colchicine for alcoholic and nonalcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev 2001:CD002148.
  36. Lieber C , Weiss D , Groszmann R , Paronetto F , Schenker S . VA Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease (effects of drinking behavior by nurse/physician teams) . Alcohol Clin Exp Res . 2003;27:1757–1764
  37. Mendenhall C , Moritz T , Roselle G , et al.   A study of oral nutritional support with oxandralone in malnourished patients with alcoholic hepatitis (a Department of Veterans Affairs cooperative study) . Hepatology . 1993;17:564–576
  38. Mato J , Camara J , Fernandez de Pz J , et al.   S-Adenosylmethionine in alcoholic liver cirrhosis (a randomized, placebo-controlled, double-blind, multicenter clinical trial) . J Hepatol . 1999;30:1081–1089

 Supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development.The views expressed herein are those of the authors and not the official position of the US Government.

PII: S0016-5085(05)00169-1

doi: 10.1053/j.gastro.2005.01.057

Gastroenterology
Volume 128, Issue 4 , Pages 882-890 , April 2005

Article Tools

* Image Usage & Resolution